Recruiting

Hip Exoskeleton

Sponsor:

Carnegie Mellon University

Code:

NCT07940127

Conditions

Healthy Volunteers

Gait

Aging

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

AI-Driven Hip Exoskeleton Assistance

Study Details

Brief summary:

The goal of this clinical trial is to evaluate the feasibility of a prototype artificial intelligence (AI)-based controller for a lightweight hip exoskeleton across a broad range of users, including healthy younger adults (18-39 years) and older adults (65 years and older). The main questions it aims to answer are:

  • Can the AI-based controller accurately estimate gait phase in real time across younger and older adults?
  • How does hip exoskeleton assistance change walking energy cost, mechanics, and muscle activity?

Researchers will compare walking with powered hip exoskeleton assistance to walking without the exoskeleton and walking while wearing the exoskeleton with no assistance (zero torque).

Participants will:

  • Complete a short screening and frailty assessment
  • Walk on a treadmill under different conditions with and without the hip exoskeleton during 2 to 5 lab visits
  • Wear motion capture markers, muscle activity (EMG) sensors, and a mask that measures breathing to estimate energy use

Conditions

Healthy Volunteers

Gait

Aging

Study ID

NCT07940127

Start date

Aug 6, 2026

Status verified date

Nov, 2026

Completion date

Jan 31, 2028

Anticipated

Primary completion date

Aug 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age 18 to 39 years (younger adult group) or 65 years and older (older adult group)
  • Willing and able to provide informed consent
  • Able to walk independently without assistance
  • No known cardiovascular, metabolic, or renal disease, and no signs or symptoms suggestive of such disease
  • Cleared for light- to moderate-intensity exercise without the need for medical clearance under American College of Sports Medicine (ACSM) preparticipation screening guidelines

Exclusion Criteria:

  • Age 40 to 64 years
  • Leg surgery within the past 5 years
  • Orthopedic disability that could impair movement or limit participation in the exercise protocol
  • Neurologic disorder that may affect neuromuscular function or gait (e.g., stroke, Parkinson's disease, peripheral neuropathy, traumatic brain injury)
  • Known metabolic or cardiovascular disease (hypertension alone is not exclusionary), or requiring medical clearance under ACSM guidelines without having obtained it
  • Metal implants in the lower extremities, cardiac pacemaker, or other implanted electronic device
  • Pregnancy
  • History of seizure disorder or fainting (syncope)

Study Design

Enrollment

16 participants

Anticipated

Intervention Model

Single group

Primary purpose

Device Feasibility

Interventions and Outcome Measures

Arms

experimental: Hip Exoskeleton Walking

Healthy younger adults (18-39 years) and older adults (65+ years) walk on an instrumented treadmill under multiple conditions across 2-5 lab visits: no exoskeleton, wearing the CMU Hip Exoskeleton with zero torque, and with powered assistance from the AI-driven hip exoskeleton controller (assistance limited to <0.2 Nm/kg). The primary objective is to evaluate real-time gait phase estimation accuracy of the prototype controller across users; metabolic cost, biomechanics, and muscle activity are recorded as secondary measures.

Interventions

AI-Driven Hip Exoskeleton Assistance

A lightweight (3.5 kg) research hip exoskeleton developed at Carnegie Mellon University with powered hip flexion/extension joints, a backpack-mounted computer and battery, and thigh and waist interfaces secured with straps. An AI-driven controller estimates the user's gait state from joint angle and wearable sensor data and commands assistive hip torque in real time, limited to <0.2 Nm/kg (peak device torque 18 Nm). Participants walk on a treadmill with powered assistance, with the device worn at zero torque, and without the device. The device was determined by the UT Austin IRB to be a non-significant risk device.

Primary outcome measure

  • Gait Phase Estimation Error of the AI-Driven Hip Exoskeleton Controller [ Time Frame: Day 1 ]

Central Contacts and Locations

Central contacts

Locations

University of Texas at Austin

Recruiting

Austin, Texas, United States, 78712

Contacts

Principal Investigator:

Owen Beck, PhD

More Information

Sponsor

Carnegie Mellon University

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Keywords

  • exoskeleton
  • hip exoskeleton
  • wearable robotics
  • artificial intelligence
  • metabolic cost
  • walking
  • older adults

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Carnegie Mellon University on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.